Siordia-Reyes AG, Ferman-Cano F, Rodríguez-Velasco A

Language: Spanish
References: 16
Page: 531-534
PDF size: 80.35 Kb.

ABSTRACT

Ki-1 anaplastic large cell non-Hodgkin lymphoma is a well recognized clinical entity. The main clinical feature includes lymphadenopathy with mediastinal sparing. In the extranodal disease, which occurs in approximately half of the cases, the skin is the most common site; bone marrow, lung and central nervous system are generally not involved. Anaplastic large cell lymphoma is more common among young people, in whom the prognosis is more favorable. Primary anaplastic large cell lymphoma of the lung is a rare clinical entity. Its clinical expression is similar to a high grade malignant lymphoma, and in most cases the diagnosis is made in advanced stages. We present a pediatric case with ALK-1 positive anaplastic large cell lymphoma of the lung.

REFERENCES

1. Rush WL, Andriko JA, Taubenberger JK, Nelson AM, Abbondazo SL, Travis WD, et al. Primary anaplastic large cell lymphoma of the lung: a clinicopathologic study of five cases. Mod Pathol Dec 2000;13(12):1285-1292.

2. 2. Beltran BS, Tomas L M y Ferreras FP. Linfoma no Hodgkin pulmonar primario anáplasico de células grandes Ki-1 positivo. Estudio de un caso y revisión de la literatura. An Med Interna 2001;18(11):587-590.

3. 3. Stein H, Foss H-D, Durkop H, Marafioti T, Delsol G, Pulford K, et al. HCD30+ anaplastic large cell lymphoma: a review of its hitospathologic, genetic and clinical features. Blood 2000;96:3681-3695.

4. 4. Phade SM, Chini BA, Patton D, Goyal RK. Relapsed non-Hodgkin´s lymphoma diagnosed by flexible bronchoscopy. Pediatric Pulmonology 2002:34;488-490.

5. 5. Chittal SM, Delsol G. The interface of Hodgkin´s disease and anaplastic large cell lymphoma. Cancer Surv 1997;39:87-105.

6. 6. Stein H. Diagnosis of Hodgkin disease. Hodgkin-like anaplastic large cell lymphoma and T cell histiocyte-rich B cell lymphoma in human lymphoma. Clinical implications of the REAL classification. Mason DY, Harris NL, ed London Springer 1999;52:0-4.

7. 7. Harris NL, Jaffe ES, Stain H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.

8. 8. Shiota M, Nakamura S, Ichinohasoma R, Abe M, Akagi T, Takeshita M, et al. Anaplastic large cell lymphoma expressing the chimeric protein p80 NPM/ALK, a distinct clinico-pathologic entity. Blood 1995;86:1954-1960.

9. 9. Falini B, Pulford K, Pucciarini A, Carbone A, De Wolf-Peeters C, Cordell J, et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999;94(10):3509-3515.

10. Vecchi V, Burnelli R, Pileri S. Anaplastic large cell lymphoma (Ki-1/CD30+) in childhood. Mod Pediatr Oncol 1998;21:402-410.

11. Murphy SB. Pediatric lymphomas. Recent advances and commentary on Ki-1 positive anaplastic large cell lymphoma on childhood. Ann Oncol 1994;5 (suppl 1):31

12. Reiter A, Schrappe M, Tiermann M, Parwaresch, Zimmerman, Yakisan E, et al. Successful treatment strategy for Ki-1 anaplastic large cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 1994;12:899-898

13. Nosari A, Cantoni S, Oreste P, Schiantarelli C, Landonio G, Alexiadis S, et al. Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients. British Journal Hematology 1996,95;508-512.

14. Menárguez J, Carrión JR. Linfomas pulmonares. Med Clin 1995;105:301-302

15. Chott A, Kaserer K, Augustin I, Vesely M, Heinz R, Oehlinger W, Hanak H, et al. Ki-1 positive large cell lymphoma. A clinicpathology study of 41 cases. Am J Surg Pathol 1990;14(5):439-48.

16. Chadburn A, Cesarman E, Jagirdar J, Subar M, Mir RN, Knowles DM. CD30 (Ki-1) positive anaplastic large cell lymphoma in individuals infected with the human immunodeficiency virus. Cancer 1993;72:3078-90.